"Once the management [at the FDA] cliff hanger is worked out then ..."stand back" a bunch of new science-trial information and plans can be made public."
Fully agree!
If the FDA continues to play politics, TGD will be submitting our clinical trial results to other regulatory agencies around the world.
Well said Nidan. Our data is before the FDA and has been from the early Ph 2a Alzheimer’s trial in AU, which was their own NEW design! They can NOT ignore us much longer and exactly how that translates into the approval “speed” is, like you said, based on the FDA saving face. Once we gain approval imo the “science” will be much easier to follow and will advance much faster. The FDA, and BP, “machine” is its own worst enemy.
"chromatin remodeling is restored, as well as post-translation proteins - which are toxic - are prevented, by preventing toxic RNA to be expressed into toxic proteins. So only healthy proteins are expressed by expressing healthy RNA".
Fantastic... said out loud and certainly with evidence to back up statement.
Market Data 
Markets 
AI
